Sure - this is how it works (as far as I can tell).It is not...

Sure - this is how it works (as far as I can tell).

It is not that it says this in the announcement, it is that BOT has to abide by the ASX rules and comply with both via continuous disclosure rules (3.1) and trading halt rules (17.1 ASX).

3.1 So firstcontinuous disclosure rules are as follows...


Now, BOT has received FDA comms.... that's how I read "pending release of announcement regarding US FDA Communications", however they did not release this information immediately, instead they requested immediate trading halt. Now a TH is only granted by the ASX if it reasonable that they have material info but cannot release to market immediately (for various reasons)

See below... TH agreed to by ASX when... a. trading maybe affected, b. false market created or they need it to manage cont disc...



Basically they should have released the info immediately, but the fact they haven't and have a TH instead means they have material info, but cannot release immediately for some reason, or trading will be affected with knowing this info... etc


DYOR and all that.

...